ArticleCancer discovery2023
Correction: Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.
No numbers read from the abstract.
ArticleCancer discovery2023
No numbers read from the abstract.